NCCN 2013 Congress Series™: Utilizing Guidelines to Customize Patient Care in Breast Cancer - Clinical Evaluation of Patients
December 17, 2013
This live activity is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with breast cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for breast cancer.
Target Audience
This activity is designed to meet the educational needs of medical oncologists, radiation oncologists, surgical oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with breast cancer.
Learning Objectives
Following this activity, participants should be able to:
- Identify the strengths and limitations of breast cancer imaging modalities such as MRI and PET/CT scanning in early diagnosis through state IV or recurrent disease
- Select patients for whom PET/CT imaging may be an appropriate supplement to standard imaging in the staging of disease
- Interpret and use nationally recognized quality control recommendations on ER/PR and HER-2 testing in breast cancer patients
Benjamin O. Anderson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information
Available Credit
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician
Price
Cost:
$0.00
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- Adobe Reader or other PDF reader software for certificate viewing/printing